Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses.

@article{Agarwal2001LisinoprilTF,
  title={Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses.},
  author={Rajiv L Agarwal and Robert T. Lewis and Joyce L Davis and Bjoern Becker},
  journal={American journal of kidney diseases : the official journal of the National Kidney Foundation},
  year={2001},
  volume={38 6},
  pages={1245-50}
}
To evaluate the antihypertensive effects of lisinopril, a renally excreted angiotensin-converting enzyme inhibitor, we assessed supervised administration of the drug after hemodialysis (HD) three times weekly. Blood pressure (BP) was assessed by interdialytic 44-hour ambulatory BP (ABP) monitoring, and endocrine responses were assessed by plasma renin activity (PRA) before and after dialysis. Lisinopril dose was titrated at biweekly intervals. If this was not effective after full titration… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2014
View 3 Excerpts

Therapeutic efficacy of renin-angiotensin blockade in patients receiving dialysis.

Therapeutic advances in cardiovascular disease • 2009
View 1 Excerpt

Thrice weekly warfarin administration in haemodialysis patients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2009
View 2 Excerpts

Similar Papers

Loading similar papers…